Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
lunes, octubre 19
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Hyperfine Inc
HYPR
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$0.7548
-0.0253
-3.24%
Últ. Act.: Oct 19, 4:22 AM
$0.7500
-0.0301
-3.86%
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Finanzas
Sentimiento
Comparar
Opciones
Privacy Manager
Hyperfine Analyst Price Targets - Benzinga
Hyperfine Analyst Price Targets
Wall Street analyst price targets and consensus rating for Hyperfine (HYPR).
Analyst Ratings News
PRO
BTIG Reiterates Buy on Hyperfine, Maintains $2 Price Target
BTIG analyst Marie Thibault reiterates Hyperfine (NASDAQ:HYPR) with a Buy and maintains $2 price target.
Benzinga Newsdesk
PRO
BTIG Reiterates Buy on Hyperfine, Maintains $2 Price Target
BTIG analyst Marie Thibault reiterates Hyperfine (NASDAQ:HYPR) with a Buy and maintains $2 price target.
Benzinga Newsdesk
PRO
B. Riley Securities Reiterates Buy on Hyperfine, Lowers Price Target to $1.6
B. Riley Securities analyst Yuan Zhi reiterates Hyperfine (NASDAQ:HYPR) with a Buy and lowers the price target from $2 to $1.6.
Benzinga Newsdesk
This Hyperfine Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Wednesday
Top analysts change outlook on Hyperfine Inc, Legence, and Aktis Oncology with Buy/Outperform ratings and price targets. See other analysts' views.
Avi Kapoor
PRO
BTIG Initiates Coverage On Hyperfine with Buy Rating, Announces Price Target of $2
BTIG analyst Marie Thibault initiates coverage on Hyperfine (NASDAQ:HYPR) with a Buy rating and announces Price Target of $2.
Benzinga Newsdesk
PRO
Lake Street Maintains Buy on Hyperfine, Raises Price Target to $2.5
Lake Street analyst Frank Takkinen maintains Hyperfine (NASDAQ:HYPR) with a Buy and raises the price target from $2 to $2.5.
Benzinga Newsdesk
Crear lista de seguimiento
GRATIS: Haz un seguimiento de acciones y criptomonedas con las mejores alertas de Internet
Haz clic para comenzar
People Also Watch
Abbott Laboratories
NYSE:ABT
$104.33
-0.54%
Intuitive Surgical Inc
NASDAQ:ISRG
$428.5
0.42%
Medtronic PLC
NYSE:MDT
$94.38
-0.39%
Stryker Corp
NYSE:SYK
$294
-0.22%
Boston Scientific Corp
NYSE:BSX
$43.91
-1.09%
Becton Dickinson & Co
NYSE:BDX
$193.71
1.01%
Edwards Lifesciences Corp
NYSE:EW
$86.6
-%
IDEXX Laboratories Inc
NASDAQ:IDXX
$560.36
-%
ResMed Inc
NYSE:RMD
$238.97
-%
DexCom Inc
NASDAQ:DXCM
$86.02
-0.02%
Muestra todas las empresas relacionadas con 10
